Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Superkrane Mitra Utama Tbk. (SKRN)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Superkrane Mitra Utama Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Superkrane Mitra Utama Tbk. diperdagangkan di Rp412 (kapitalisasi pasar 3,14 T, volume 24 jam 158 rb). Perbedaan utamanya: Superkrane Mitra Utama Tbk. jauh lebih besar — sekitar 30,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SKRN | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 3,14 T |
Volume | — | 158 rb |
Lot | — | 1,58 rb |
Perputaran | — | 64,61 jt |
Harga Rata-rata | — | 408,9 |
Nilai Transaksi | — | 64,61 jt |
Harga Ekuilibrium Indikatif | — | 412 |
Volume Ekuilibrium Indikatif | — | 122 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Superkrane Mitra Utama Tbk.
PT Superkrane Mitra Utama Tbk (the Company) was established based on Deed No. 285 by notary Ratna Komala Komar, S.H., dated March 27, 1996, in Jakarta.
Selengkapnya di halaman SKRN →
